| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Allogene Therapeutics, Inc.
13G/A
ALLO · 019770106
|
4.9% |
5/13/2026
Event 3/31/2026
|
||||
| David D. Chang, M.D., Ph.D. | 4.9% | |||||
| Chang 2006 Family Trust | 0.5% | |||||
| JEC 2019 Trust | 0.3% | |||||
| RTC 2019 Trust | 0.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.